Baker Brothers Advisors - INOZYME PHARMA INC ownership

INOZYME PHARMA INC's ticker is INZY and the CUSIP is 45790W108. A total of 51 filers reported holding INOZYME PHARMA INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of INOZYME PHARMA INC
ValueSharesWeighting
Q2 2022$510,000
+16.4%
106,9990.0%0.00%0.0%
Q1 2022$438,000
-40.0%
106,9990.0%0.00%
-25.0%
Q4 2021$730,000
-41.1%
106,9990.0%0.00%
-20.0%
Q3 2021$1,240,000
-32.0%
106,9990.0%0.01%
-37.5%
Q2 2021$1,823,000
-14.0%
106,9990.0%0.01%
-11.1%
Q1 2021$2,119,000
-4.0%
106,9990.0%0.01%
+12.5%
Q4 2020$2,208,000
-29.1%
106,999
-9.7%
0.01%
-33.3%
Q3 2020$3,115,000118,5000.01%
Other shareholders
INOZYME PHARMA INC shareholders Q2 2021
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 4,494,851$18,878,3747.53%
CHI Advisors LLC 1,270,027$5,334,1122.11%
Samsara BioCapital, LLC 1,562,500$6,562,5002.01%
Affinity Asset Advisors, LLC 1,379,852$5,795,3781.63%
Sofinnova Investments, Inc. 4,280,308$17,977,2941.13%
SPHERA FUNDS MANAGEMENT LTD. 1,234,907$5,186,6090.94%
Octagon Capital Advisors LP 1,300,000$5,460,0000.84%
NEA Management Company, LLC 2,437,689$10,238,2940.79%
Knott David M Jr 454,008$1,9070.73%
Rock Springs Capital Management LP 3,681,174$15,460,9310.41%
View complete list of INOZYME PHARMA INC shareholders